Clinical data gaps keeping life-saving antibiotics from children

pexels-cottonbro-5858738

Antibiotics that could treat severe infections in babies and children aren’t accessible due to a lack of data around safety and dosage. Of 12 antibiotics recommended for serious bloodstream infections caused by a harmful, Gram-negative bacteria, only six were licensed in children aged under 12 and just three in babies. 

 Registered users, subscribers or members - SIGN IN

To continue reading this article

Membership

Included as a benefit

Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.

I AM A MEMBER

Find out more about how to join.

 

Register

FREE

Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.

REGISTER

 

Subscribe

3.75 per month / £35 annually

Get unlimited access to The Microbiologist.

SUBSCRIBE